Capreomycin sulfate indications and usage: Difference between revisions

Jump to navigation Jump to search
(Created page with "__NOTOC__ {{Capreomycin sulfate}} {{CMG}} ; {{AE}}{{chetan}} <ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = CAPASTAT SULFATE (CAPREOMYCIN) INJE...")
 
No edit summary
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Capreomycin sulfate}}
{{Capreomycin sulfate}}
{{CMG}} ; {{AE}}{{chetan}}
{{CMG}} ; {{AE}} {{chetan}}






<ref name="dailymed.nlm.nih.gov">{{Cite web  | last =  | first =  | title = CAPASTAT SULFATE (CAPREOMYCIN) INJECTION, POWDER, FOR SOLUTION [AKORN] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=808e4421-2b9c-41e1-a82c-39256b112ae8 | publisher =  | date =  | accessdate = 24 December 2013 }}</ref>
<ref name="dailymed.nlm.nih.gov">{{Cite web  | last =  | first =  | title = CAPASTAT SULFATE (CAPREOMYCIN) INJECTION, POWDER, FOR SOLUTION [AKORN] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=808e4421-2b9c-41e1-a82c-39256b112ae8 | publisher =  | date =  | accessdate }}</ref>


==References==
==References==

Revision as of 21:58, 24 December 2013

Capreomycin Sulfate
CAPASTAT SULFATE® FDA Package Insert
Description
Clinical Pharmacology
Microbiology
Indications and Usage
Contraindications
Warnings and Precautions
Adverse Reactions
Overdosage
Dosage and Administration
How Supplied
Labels and Packages

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Chetan Lokhande, M.B.B.S [2]


[1]

References

  1. "CAPASTAT SULFATE (CAPREOMYCIN) INJECTION, POWDER, FOR SOLUTION [AKORN]". Text " accessdate " ignored (help)

Adapted from the FDA Package Insert.